Eli Lilly (LLY) said Thursday it has expanded its LillyDirect digital platform to add tools that link to in-person and telehealth providers for people in the US with Alzheimer's disease.
In contrast with other conditions on the platform, the resources for Alzheimer's disease won't include mail order pharmacy options to Lilly drugs but will focus on education and ways to connect people with independent provider options, according to the company.
The new options include independent doctor locator tool Healthgrades and a link to Synapticure, Eli Lilly said.
Price: 822.71, Change: -4.05, Percent Change: -0.49
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.